Covid19 Infectious Diseases Real World Data & Wearables
Study Description
IPF VACCINE is a study to record and monitor Idiopathic pulmonary fibrosis (IPF) patients of the Agostino Gemelli IRCCS University Hospital Foundation after the administration of their vaccination. Healthentia application will be used to collect through questionnaires, any side effects that occurred on the day of vaccination and the following seven days.
Study Details
Type: Multicentric
Disease: Covid 19 Surveillance of positive tests
Primary Site: Fondazione Policlinico Gemelli
Start: March 2021
Population: Outpatient pulmonary adults with documented positive SARS-CoV-2 test
Duration: Ongoing
Study Design & Methods
All participants will download Healthentia application and register. For a period of 7 days the user is asked, through an agile questionnaire, to report any side effects that occurred on the day of vaccination and the next seven days.
